These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12661981)

  • 21. Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
    Ciraulo DA; Sarid-Segal O; Knapp CM; Ciraulo AM; LoCastro J; Bloch DA; Montgomery MA; Leiderman DB; Elkashef A
    Addiction; 2005 Mar; 100 Suppl 1():12-22. PubMed ID: 15730346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.
    Abdelmalik N; Ruhé HG; Barwari K; van den Dool EJ; Meijers JC; Middeldorp S; Büller HR; Schene AH; Kamphuisen PW
    J Thromb Haemost; 2008 Dec; 6(12):2168-74. PubMed ID: 18983505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression.
    Stain-Malmgren R; Tham A; Aberg-Wistedt A
    J ECT; 1998 Mar; 14(1):15-24. PubMed ID: 9661089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
    Smedh K; Spigset O; Allard P; Mjörndal T; Adolfsson R
    Biol Psychiatry; 1999 Feb; 45(4):464-70. PubMed ID: 10071719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
    Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
    Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders.
    Ramacciotti CE; Coli E; Paoli R; Marazziti D; Dell'Osso L
    Psychiatry Res; 2003 May; 118(1):33-8. PubMed ID: 12759159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults.
    Sigurdh J; Spigset O; Allard P; Mjörndal T; Hägglöf B
    Neuropsychobiology; 1999 Nov; 40(4):183-7. PubMed ID: 10559700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
    Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
    Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet paroxetine binding in post-traumatic stress disorder.
    Maguire K; Norman T; Burrows G; Hopwood M; Morris P
    Psychiatry Res; 1998 Jan; 77(1):1-7. PubMed ID: 10710169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
    Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A
    Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis.
    Ramaiya A; Johnson JH; Karnes HT
    J Pharm Sci; 1997 Dec; 86(12):1497-500. PubMed ID: 9423168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.